Pharmaceutical - UK

Filter

Current filters:

UK

Popular Filters

1 to 25 of 216 results

Avillion appoints Jarrod Longcor as chief business officer

Avillion appoints Jarrod Longcor as chief business officer

23-09-2014

UK-based Avillion LLP, a co-developer of late-stage pharmaceutical assets, has named Jarrod Longcor as…

Avillion LLPBoardroomBosulifPharmaceuticalUK

Allergy Therapeutics shows increase in revenue in preliminary results

Allergy Therapeutics shows increase in revenue in preliminary results

22-09-2014

UK-based Allergy Therapeutics has announced its preliminary results for the year ended June 30, 2014,…

Allergy TherapeuticsFinancialPharmaceuticalPollinex QuattroRespiratory and PulmonaryUK

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

22-09-2014

UK-based Skyepharma, an oral and inhalation drug delivery company, has given notice to CRC European Loan…

AnalgesiaExparelFinancialPacira PharmaceuticalsPharmaceuticalSkyepharmaUKUSA

NICE and ABPI call for reform of drug appraisals after consultation

NICE and ABPI call for reform of drug appraisals after consultation

18-09-2014

The UK’s Association of the British Pharmaceutical Industry (ABPI) has called for a “more ambitious…

Care ExcellenceHealthcareNHSPharmaceuticalUK

UK NICE consults on draft guidance for hepatitis C drug Olysio

UK NICE consults on draft guidance for hepatitis C drug Olysio

18-09-2014

In draft guidance published today UK drugs watchdog the National Institute for Health and Care Excellence…

Anti-viralsJanssenJohnson & JohnsonOlysioPharmaceuticalPricingRegulationUK

UK’s NICE proposes to recommend GSK’s Tafinlar for melanoma

UK’s NICE proposes to recommend GSK’s Tafinlar for melanoma

18-09-2014

UK drugs watchdog the National Institute for Health and Care Excellence (NICE) has issued final draft…

GlaxoSmithKlineOncologyPharmaceuticalPricingRegulationRocheTafinlarUKZelboraf

Lilly to pay up to $500 million for AstraZeneca Alzheimer’s candidate

Lilly to pay up to $500 million for AstraZeneca Alzheimer’s candidate

16-09-2014

Anglo-Swedish pharma major AstraZeneca and US peer Eli Lilly have entered an agreement to jointly develop…

AstraZenecaAZD3293Eli LillyLicensingNeurologicalPharmaceuticalResearchUKUSA

UK M&A regulator consults on more stringent regulations

UK M&A regulator consults on more stringent regulations

16-09-2014

Partly in response to the recent (failed, thus far) attempt by US pharma giant Pfizer to acquire Anglo-Swedish…

LegalMergers & AcquisitionsPfizerPharmaceuticalUK

ABPI and Department of Health announce second PPRS payment

ABPI and Department of Health announce second PPRS payment

12-09-2014

The Association of the British Pharmaceutical Industry (ABPI) and the UK Department of Health have announced…

Association of the British Pharmaceutical IndustryNHS EnglandPharmaceuticalRegulationUK

Norgine sells certain rights for Camcolit and Somnite to Essential Pharma

11-09-2014

Netherlands-headquartered independent drugmaker Norgine has agreed to sell all rights in the UK for Somnite…

Essential PharmaIrelandLicensingNeurologicalNorginePharmaceuticalUK

Sophia Genetics in deal with Britain's NHS, and a leading Turkish lab

11-09-2014

Sophia Genetics, a European leader in data driven medicine, has significantly expanded its European customer…

PharmaceuticalProductionResearchSophia GeneticsTurkeyUK

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

09-09-2014

UK pharma giant GlaxoSmithKline today announced a £5 million ($8.2 million) collaboration with the UK…

FinancialGlaxoSmithKlinePharmaceuticalResearchSouth AfricaUK

GSK reports positive Phase III results of its mepolizumab in asthma

GSK reports positive Phase III results of its mepolizumab in asthma

08-09-2014

UK pharma major GlaxoSmithKline has reported positive data from its Phase III asthma studies of mepolizumab,…

GlaxoSmithKlineGSKImmunosuppressantsmepolizumabMepolizumabPharmaceuticalResearchRespiratory and PulmonaryUK

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

Bristol-Myers Squibb launches Daklinza in the UK for chronic hepatitis C

03-09-2014

US drug major Bristol-Myers Squibb has launched Daklinza (daclastavir) in the UK for chronic hepatitis…

AntiviralsBristol-Myers SquibbDaklinzaHepatitis CNephrology and HepatologyPharmaceuticalRegulationUK

NHS England boosts the Cancer Drugs Fund for more access to innovative medicines

NHS England boosts the Cancer Drugs Fund for more access to innovative medicines

28-08-2014

The National Health Service England has pledged to boost the Cancer Drugs Fund by £160 million ($265…

Cancer Drugs FundNHS EnglandOncologyPharmaceuticalRegulationUK

UK NICE wants more info on type 2 diabetes drug Jardiance

UK NICE wants more info on type 2 diabetes drug Jardiance

28-08-2014

In a new draft guidance issued today, the UK drugs watchdog the National Institute for Health and Care…

Boehringer IngelheimDiabetesEli LillyJardiancePharmaceuticalPricingRegulationUK

Insulin offers new hope for the treatment of acute pancreatitis

22-08-2014

Acute pancreatitis involves the pancreas digesting itself resulting in severe abdominal pain, vomiting…

DiabetesInflammatory diseasesPancreas disordersPharmaceuticalResearchUK

1 to 25 of 216 results

Back to top